Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Pacific Biosciences (PACB)

Pacific Biosciences (PACB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,347,102
  • Shares Outstanding, K 180,213
  • Annual Sales, $ 78,890 K
  • Annual Income, $ 29,400 K
  • 60-Month Beta 1.14
  • Price/Sales 69.83
  • Price/Cash Flow N/A
  • Price/Book 37.17
Trade PACB with:

Options Overview

Details
  • Implied Volatility 115.19%
  • Historical Volatility 119.90%
  • IV Percentile 75%
  • IV Rank 30.80%
  • IV High 248.96% on 05/11/20
  • IV Low 55.67% on 08/28/20
  • Put/Call Vol Ratio 0.17
  • Today's Volume 7,784
  • Volume Avg (30-Day) 6,822
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 59,333
  • Open Int (30-Day) 51,397

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.17
  • Low Estimate -0.49
  • Prior Year -0.16
  • Growth Rate Est. (year over year) -131.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
30.15 +16.82%
on 02/26/21
53.69 -34.40%
on 02/11/21
+1.04 (+3.04%)
since 02/01/21
3-Month
16.70 +110.90%
on 12/02/20
53.69 -34.40%
on 02/11/21
+17.27 (+96.21%)
since 12/01/20
52-Week
2.20 +1,500.91%
on 03/18/20
53.69 -34.40%
on 02/11/21
+31.82 (+935.88%)
since 02/28/20

Most Recent Stories

More News
Thinking about trading options or stock in Johnson & Johnson, MicroStrategy, Bank of America, Plug Power, or Pacific Biosciences?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for JNJ, MSTR, BAC, PLUG, and PACB.

MSTR : 782.44 (+4.27%)
PACB : 35.22 (+15.21%)
PLUG : 52.46 (+8.43%)
BAC : 35.79 (+3.11%)
JNJ : 159.32 (+0.54%)
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences:

PACB : 35.22 (+15.21%)
Children's Mercy Kansas City Expands Investment in Pacific Biosciences Sequel IIe Systems to Scale Up Whole Genome Research Initiatives Focused on Rare Disease Diagnosis

Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children's Mercy Kansas City, one of the nation's top pediatric...

PACB : 35.22 (+15.21%)
Pacific Biosciences' (PACB) Sequel II Gets Deployed by LabCorp

Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.

ANGO : 21.26 (+1.48%)
HOLX : 74.64 (+3.54%)
LH : 241.50 (+0.66%)
PACB : 35.22 (+15.21%)
5 Stocks That Make Ark Innovation ETF (ARKK) Red Hot

ARKK is centered around the idea of disruptive innovation, which is defined as the introduction of a technologically-enabled new product or service that potentially changes the way the world works.

SSYS : 36.28 (+5.19%)
TSLA : 718.43 (+6.36%)
PACB : 35.22 (+15.21%)
TDOC : 223.39 (+1.04%)
VCYT : 62.89 (+8.32%)
VOO : 358.12 (+2.44%)
ARKK : 136.70 (+4.86%)
HUYA : 27.55 (+4.55%)
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company,...

LH : 241.50 (+0.66%)
PACB : 35.22 (+15.21%)
Pacific Bioscien Shares Up 29.3% Since SmarTrend's Buy Recommendation (PACB)

SmarTrend identified an Uptrend for Pacific Bioscien (NASDAQ:PACB) on February 2nd, 2021 at $35.88. In approximately 2 weeks, Pacific Bioscien has returned 29.33% as of today's recent price of $46.41....

PACB : 35.22 (+15.21%)
Tumor Genomics Market Size to Reach USD 56.54 Billion by 2028 | Global Analysis, Industry Statistics, Revenue, Demand and Trend Analysis Research Report by Emergen Research

The global tumor genomic market size was USD 21.42 Billion in 2020 and is expected to reach a market size of USD 56.54 Billion by 2028 and register a CAGR of 12.8%, over the forecast period, according...

ILMN : 446.50 (+1.61%)
MKKGY : 32.8800 (+0.95%)
MYGN : 30.86 (+1.21%)
PACB : 35.22 (+15.21%)
Pacific Biosciences (PACB) Q4 Earnings and Revenues Miss Estimates

Pacific Biosciences (PACB) suffers a Product revenue decline in the fourth quarter.

ANGO : 21.26 (+1.48%)
HOLX : 74.64 (+3.54%)
ABT : 122.21 (+2.03%)
PACB : 35.22 (+15.21%)
Report 2021 - DNA Sequencing Market Size, Share, Growth, Revenue, Trends, Competitive Landscape, Forecast Report

According to the report, DNA Sequencing market size is projected to reach remarkable value by 2026. The rising advancements in DNA sequencing technologies is expected to enable growth of the global DNA...

ILMN : 446.50 (+1.61%)
MKKGY : 32.8800 (+0.95%)
PACB : 35.22 (+15.21%)
PKI : 129.72 (+2.88%)
SIEGY : 78.9100 (+1.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed...

See More

Key Turning Points

3rd Resistance Point 40.51
2nd Resistance Point 38.10
1st Resistance Point 36.66
Last Price 35.22
1st Support Level 32.81
2nd Support Level 30.40
3rd Support Level 28.96

See More

52-Week High 53.69
Last Price 35.22
Fibonacci 61.8% 34.02
Fibonacci 50% 27.94
Fibonacci 38.2% 21.87
52-Week Low 2.20

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar